› Forums › General Melanoma Community › TIL therapy survey for stage III and IV unresectable cutaneous melanoma patients
- This topic has 0 replies, 1 voice, and was last updated 4 years ago by
Amy-MRF.
- Post
-
- March 16, 2021 at 4:17 pm
Our partners at Iovance want to learn more about your understanding and perspective of TIL Therapy. In support, the MRF is conducting a survey that is open to patients, thrivers and survivors who were diagnosed with stage III to stage IV unresectable melanoma. Follow this link to learn more: https://www.surveymonkey.com/r/7NXR83V
- You must be logged in to reply to this topic.